• 1
    Ludvigsson JF, Lefner DA, Bai JC, et al. The Oslo definitions for celiac disease and related terms. Gut 2013; 62: 4352.
  • 2
    Ventura A, Magazzu G, Greco L and the SIGEP Study Group. Duration of gluten exposure and risk of autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297303
  • 3
    Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 23442.
  • 4
    Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin Gastroenterol 2006; 22: 6749.
  • 5
    Curione M, Barbato M, Viola F, Francia P, De Biase L, Cucchiara S. Idiopathic dilated cardiomyopathy associated with coeliac disease: the effect of a gluten-free diet on cardiac performance. Dig Liver Dis 2002; 34: 8669.
  • 6
    Bardella MT, Cantù P, Cesana BM, Piodi LP. Severe heart disease in celiac sprue and inflammatory bowel disease: a common pathogenesis. Scand J Gastroenterol 2004; 39: 13045.
  • 7
    Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation 2002; 105: 26118.
  • 8
    Van Leuven SI, Kastelein JJ, D'Cruz DP, Hughes GR, Stroes ES. Atherogenesis in rheumatology. Lupus 2006; 15: 11721.
  • 9
    Ahmad Y, Shelmerdine J, Bodill H, et al. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology 2007; 46: 9838.
  • 10
    Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Int Med 2006; 144: 24956.
  • 11
    Szucs G, Timar O, Szekanecz Z, et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis – relevance for prevention of vascular complication. Rheumatology 2007; 46: 75962.
  • 12
    >Hannawi S, Haluska B, Marwick TH, Thomas R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 2007; 9: R116.
  • 13
    Del Rincòn I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003; 48: 183340.
  • 14
    Viljama M, Kaurinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: a 30-year population-based study. Dig Liv Dis 2006; 38: 37480.
  • 15
    Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population based Swedish cohort. Arch Intern Med 2003; 163: 156672.
  • 16
    Capristo E, Addolorato G, Mingrone G, Scarfone A, Greco A, Gasbarrini G. Low serum high density lipoprotein cholesterol concentration as a sign of celiac disease. Am J Gastroenterol 2000; 95: 33312.
    Direct Link:
  • 17
    Choi BG, Vilahur G, Viles-Gonzales JF, Badimon JJ. The role of high density lipoprotein cholesterol in atherothrombosis. Mt Sinai J Med 2006; 73: 690701.
  • 18
    West J, Logan RFA, Card TR, Smith C, Hubbard R. Risk of vascular disease in adults with diagnosed celiac disease: a population-based study. Aliment Pharmacol Ther 2004; 20: 739.
  • 19
    Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994; 14: 188591.
  • 20
    Lamont D, Parker L, White M, et al. Risk of cardiovascular disease measured by carotid intima-media thickness at age 49–51: lifecourse study. BMJ 2000; 320: 2738.
  • 21
    Simons CG, Algra A, Bots ML, Grobbee DE, van der Graaf Y, SMART study group. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study. Circulation 1999; 100: 9517.
  • 22
    Takase B, Uehata A, Akima T. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82: 15359.
  • 23
    Celermajer DS, Sorensen KE, Goock VM, et al. Non invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 11115.
  • 24
    Sorensen KE, Celermajer DS, Spiegelhalter DJ. Non-invasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. Br Heart J 1995; 74: 24753.
  • 25
    Arosio E, De Marchi S, Rigoni A, Prior M, Delva P, Lechi A. Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 2007; 25: 12738.
  • 26
    Luo X, Yang Y, Cao T, Li Z. Difference in right and left carotid intima media thickness and the associated risk factors. Clin Radiol 2011; 66: 3938.
  • 27
    Wahab PJ, Meijer JWR, Mulder CJJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002; 118: 45963.
  • 28
    Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 19812002.
  • 29
    Chiarioni G, Bassotti G, Germani U, et al. Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease. Dig Dis Sci 1997; 42: 21005.
  • 30
    Bruce IN. Atherogenesis and autoimmune disease: the model of Lupus. Lupus 2005; 14: 68790.
  • 31
    Bernstein CM, Wajda A, Blanchard JF. The incidence of arterial thromboembolic disease in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008; 6: 415.
  • 32
    Dorn SD, Sandler RS. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007; 102: 6627.
  • 33
    Whorwell PJ, Alderson MR, Foster KJ, Wright R. Death from ischemic heart-disease and malignancy in adult patients with coeliac disease. Lancet 1976; 2: 1134.
  • 34
    Wei L, Spiers E, Reynolds N, Walsh S, Fahey T, McDonald TM. Association between celiac disease and cardiovascular disease. Aliment Pharmacol Ther 2008; 27: 5149.
  • 35
    Ciacci C, Cirillo M, Giorgetti G, et al. Low plasma cholesterol: a correlate of nondiagnosed celiac disease in adults with hypochromic anemia. Am J Gastroenterol 1999; 94: 188891.
    Direct Link:
  • 36
    Brar P, Kwon GY, Holleran S, et al. Change in lipid profile in celiac disease: beneficial effect of a gluten-free diet. Am J Med 2006; 119: 78690.
  • 37
    Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet. Am J Gastroenterol 2006; 101: 23569.
    Direct Link:
  • 38
    Hallert C, Grant C, Grehn S, et al. Evidence of poor vitamin status in celiac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther 2006; 16: 13339.
  • 39
    Barter PJ, Rye KA. Homocysteine and cardiovascular disease: is HDL the link? Circ Res 2006; 99: 5656.
  • 40
    Varga EA, Sturm AC, Misita PC, Moll S. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation 2005; 111: e28993.
  • 41
    Hutchinson JM, Robbins G, Howdle PD. Advances in celiac disease. Curr Opin Gastroenterol 2008; 24: 12934.
  • 42
    Williams KJ, Feig JE, Fisher EA. Rapid regression of atherosclerosis: insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med 2008; 5: 91102.
  • 43
    Wahlqvist ML, Relf IR, Myers KA, Lo CS. Diabetes and microvascular disease: risk factors for atherogenesis and non-invasive investigation of arterial disease. Hum Nutr Clin Nutr 1984; 38: 17584.
  • 44
    Woolf K, Manore MM. Elevated plasma homocysteine and low vitamin B-6 status in non-supplementing older women with rheumatoid arthritis. J Am Diet Assoc 2008; 108: 44353.
  • 45
    Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002; 39: 25765.
  • 46
    Murray JA, Rubio-Tapia A, Van Dyke CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008; 6: 18693.
  • 47
    Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation 2003; 107: 310916.